New Treatment Insights into Pancreatic Acinar Cell Carcinoma: Case Report and Literature Review
Overview
Affiliations
Pancreatic acinar cell carcinoma (PACC) is a rare pancreatic malignancy with unique clinical, molecular, and morphologic features. The long-term survival of patients with PACC is substantially better than that of patients with ductal adenocarcinoma of the pancreas. Surgical resection is considered the first choice for treatment; however, there is no standard treatment option for patients with inoperable disease. The patient with metastatic PACC reported herein survived for more than 5 years with various treatments including chemotherapy, radiotherapy, antiangiogenic therapy and combined immunotherapy.
Bhattacharjee K, Ghosh A PLoS One. 2025; 20(1):e0313738.
PMID: 39869563 PMC: 11771905. DOI: 10.1371/journal.pone.0313738.
de Jesus V, Donadio M, de Brito A, Gentilli A Ther Adv Med Oncol. 2024; 16:17588359241265213.
PMID: 39072242 PMC: 11282540. DOI: 10.1177/17588359241265213.